Encompass Health Corp (NYSE:EHC) Expected to Post Quarterly Sales of $1.15 Billion

Wall Street analysts expect that Encompass Health Corp (NYSE:EHC) will announce $1.15 billion in sales for the current quarter, according to Zacks. Seven analysts have provided estimates for Encompass Health’s earnings, with the lowest sales estimate coming in at $1.14 billion and the highest estimate coming in at $1.16 billion. Encompass Health posted sales of $1.07 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 7.5%. The firm is expected to report its next quarterly earnings results on Monday, November 4th.

On average, analysts expect that Encompass Health will report full year sales of $4.58 billion for the current fiscal year, with estimates ranging from $4.56 billion to $4.60 billion. For the next fiscal year, analysts expect that the company will post sales of $4.82 billion, with estimates ranging from $4.73 billion to $4.93 billion. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Encompass Health.

EHC has been the topic of several recent research reports. BMO Capital Markets initiated coverage on Encompass Health in a research report on Thursday, June 27th. They set an “outperform” rating and a $72.00 target price on the stock. Barclays raised Encompass Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $68.00 to $70.00 in a research report on Thursday, May 30th. Finally, Raymond James lowered their price target on Encompass Health from $80.00 to $75.00 and set an “outperform” rating for the company in a research report on Wednesday, July 31st. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $75.75.

EHC traded down $1.57 during trading on Wednesday, hitting $61.61. 271,330 shares of the stock were exchanged, compared to its average volume of 817,666. The stock has a 50 day moving average price of $63.82. The firm has a market capitalization of $6.33 billion, a price-to-earnings ratio of 16.97, a price-to-earnings-growth ratio of 2.11 and a beta of 0.83. Encompass Health has a 1 year low of $56.74 and a 1 year high of $82.46. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.12 and a current ratio of 1.12.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be issued a $0.28 dividend. The ex-dividend date is Monday, September 30th. This is a boost from Encompass Health’s previous quarterly dividend of $0.27. This represents a $1.12 dividend on an annualized basis and a yield of 1.82%. Encompass Health’s dividend payout ratio is currently 29.75%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Read More: Oversold

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit